Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis

Table 1 Human epidermal growth factor receptor 2 expression in the liver metastatic foci in gastric cancer patients

Parameter	Patient (n)	HER2 + patients (n)	Ratio (%)	Pvalue
Age (yr)
< 60	59	29	49.2	< 0.05
≥ 60	25	8	32
Gender
Male	66	28	42.4	> 0.05
Female	18	7	38.9
Tumor type
Intestinal	49	23	46.9	< 0.05
Diffuse	35	9	25.7

The proportion of patients with human epidermal growth factor receptor 2 (HER2) over-expression was higher in patients with gastric cancer (GC) of the intestinal-type than in those with GC of the diffuse-type.